4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000100
Chief Executive Officer sold 10,700 shares at $27.24 ($291,441)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2026-07-13 | Sale 10b5-1 | −10,700 | $27.24 | $291,441 | 603,621 | D |
| Open-market sales · 10,700 sh · avg $27.24 · $291,441 | |||||||
Loading xslF345X06/wk-form4_1784163491.xml…